Evaluation of potential instruments for quantifying necrobiosis lipoidica severity via physician evaluation and patient-reported outcomes.

Hashemi, David A; Nelson, Caroline A; Nyberg, Mary; Das, Maya; Rosenbach, Misha

Hashemi, David A; Nelson, Caroline A; Nyberg, Mary; Das, Maya; Rosenbach, Misha.

Afiliação

Hashemi DA; Harvard Combined Dermatology Residency Training Program, Harvard Medical School, Boston, Massachusetts.
Nelson CA; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
Nyberg M; Processa Pharmaceuticals, Hanover, Maryland.
Das M; Processa Pharmaceuticals, Hanover, Maryland.
Rosenbach M; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: Misha.Rosenbach@pennmedicine.upenn.edu.

J Am Acad Dermatol ; 89(6): 1305-1306, 2023 12.

Article em En | MEDLINE | ID: mdl-37633461

Assuntos

Necrobiose Lipoídica; Humanos; Necrobiose Lipoídica/diagnóstico; Medidas de Resultados Relatados pelo Paciente

Palavras-chave

color; diabetes; granulomatous disease; inflammation/inflammatory; medical dermatology; necrobiosis lipoidica; quality of life; ulcers

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Necrobiose Lipoídica Limite: Humans Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google